Literature DB >> 29387230

Differentially expressed miRNAs in hepatocellular carcinoma cells under hypoxic conditions are associated with transcription and phosphorylation.

Bo Hu1, Wei-Guo Tang1, Jia Fan1,2, Yang Xu1, Hai-Xiang Sun1.   

Abstract

Hypoxia is a critical aspect of tumor biology and has been associated with poor prognosis and resistance to traditional therapy. In the present study, differentially expressed genes and microRNAs (miRNAs/miRs) were screened for in the hepatocellular carcinoma (HCC) cell line Huh7 under hypoxic conditions. On the basis of microarray data, 11,508 mRNAs and 58 miRNAs exhibiting ≥1.5-fold change in expression under hypoxic conditions were identified. Gene Ontology (GO) and Kyoto Encyclopedia or Genes and Genomes pathway analysis revealed that the differentially expressed genes were primarily involved in cell cycle regulation, cell division, transcription and G-protein-coupled receptor signaling pathways. Using the TargetScan and miRanda software packages with the miRNA-mRNA negative expression network, differentially expressed miRNA targets were predicted. GO analysis revealed that the primary function of these miRNAs was to regulate transcription and phosphorylation. The miRNA-mRNA networks for transcription and phosphorylation were analyzed. Network analysis revealed that the key miRNAs in these networks were miR-19a, miR-34a, miR-29a, mir-196a, miR-25 and miR-1207, whose potential gene targets include DNA-binding proteins, zinc-finger proteins and transcription factors. Certain protein kinases, includingmitogen-activated protein kinase (MAPK) 1, MAPK kinase kinase4 and cyclin-dependent kinase 18, were also revealed to be present in the network. In hypoxic HCC tissue, levels of several key miRNAs implicated in the network analyses (miR-19a, miR-34a, miR-25 and miR-1207) were revealed to exhibit increased expression levels compared with the surrounding tissue. The results of the present study provide evidence that miRNAs serve an important function in transcription and phosphorylation in the hypoxic response of HCC cells.

Entities:  

Keywords:  hepatocellular carcinoma; hypoxia; microRNA; phosphorylation; transcription

Year:  2017        PMID: 29387230      PMCID: PMC5768078          DOI: 10.3892/ol.2017.7349

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Corrigendum. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

Authors:  Matjaz Rokavec; Meryem Gülfem Öner; Huihui Li; Rene Jackstadt; Longchang Jiang; Dmitri Lodygin; Markus Kaller; David Horst; Paul K Ziegler; Sarah Schwitalla; Julia Slotta-Huspenina; Franz G Bader; Florian R Greten; Heiko Hermeking
Journal:  J Clin Invest       Date:  2015-03-02       Impact factor: 14.808

3.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Authors:  Shu-Hao Hsu; Bo Wang; Janaiah Kota; Jianhua Yu; Stefan Costinean; Huban Kutay; Lianbo Yu; Shoumei Bai; Krista La Perle; Raghu R Chivukula; Hsiaoyin Mao; Min Wei; K Reed Clark; Jerry R Mendell; Michael A Caligiuri; Samson T Jacob; Joshua T Mendell; Kalpana Ghoshal
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

4.  Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.

Authors:  Xiaofang Xu; Renbing Jia; Yixiong Zhou; Xin Song; Jing Wang; Guanxiang Qian; Shengfang Ge; Xianqun Fan
Journal:  Int J Oncol       Date:  2011-03-03       Impact factor: 5.650

5.  An allelic series of miR-17 ∼ 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron.

Authors:  Yoon-Chi Han; Joana A Vidigal; Ping Mu; Evelyn Yao; Irtisha Singh; Alvaro J González; Carla P Concepcion; Ciro Bonetti; Paul Ogrodowski; Brett Carver; Licia Selleri; Doron Betel; Christina Leslie; Andrea Ventura
Journal:  Nat Genet       Date:  2015-06-01       Impact factor: 38.330

6.  MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.

Authors:  Guangxian Xu; Yilin Zhang; Jun Wei; Wei Jia; Zhaohui Ge; Zhaobo Zhang; Xiaoming Liu
Journal:  BMC Cancer       Date:  2013-10-10       Impact factor: 4.430

7.  miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.

Authors:  Jing Y Krzeszinski; Wei Wei; HoangDinh Huynh; Zixue Jin; Xunde Wang; Tsung-Cheng Chang; Xian-Jin Xie; Lin He; Lingegowda S Mangala; Gabriel Lopez-Berestein; Anil K Sood; Joshua T Mendell; Yihong Wan
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

8.  Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells.

Authors:  Tian-Yi Zhou; Lin-Han Zhuang; Yan Hu; Yu-Lu Zhou; Wen-Kai Lin; Dan-Dan Wang; Zi-Qian Wan; Lin-Lin Chang; Ying Chen; Mei-Dan Ying; Zi-Bo Chen; Song Ye; Jian-Shu Lou; Qiao-Jun He; Hong Zhu; Bo Yang
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

9.  Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.

Authors:  Alan Ka-Lun Kai; Lo Kong Chan; Regina Cheuk-Lam Lo; Joyce Man-Fong Lee; Carmen Chak-Lui Wong; Jack Chun-Ming Wong; Irene Oi-Lin Ng
Journal:  Hepatology       Date:  2016-04-30       Impact factor: 17.425

10.  Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif.

Authors:  Mark P Hamilton; Kimal Rajapakshe; Sean M Hartig; Boris Reva; Michael D McLellan; Cyriac Kandoth; Li Ding; Travis I Zack; Preethi H Gunaratne; David A Wheeler; Cristian Coarfa; Sean E McGuire
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  7 in total

1.  miRNA-34a suppresses colon carcinoma proliferation and induces cell apoptosis by targeting SYT1.

Authors:  Haichao Lu; Liang Hao; Hongfan Yang; Jianshe Chen; Jinxin Liu
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

2.  Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.

Authors:  Sonam Takkar; Vikas Sharma; Sourabh Ghosh; Ashish Suri; Chitra Sarkar; Ritu Kulshreshtha
Journal:  Cell Oncol (Dordr)       Date:  2021-01-19       Impact factor: 6.730

3.  miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells.

Authors:  Yong Li; Ping Gong; Ji-Xue Hou; Wei Huang; Xiao-Ping Ma; Yu-Li Wang; Jing Li; Xiao-Bin Cui; Na Li
Journal:  J Immunol Res       Date:  2018-08-02       Impact factor: 4.818

4.  Hypoxia Enhances Activity and Malignant Behaviors of Colorectal Cancer Cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT Axis.

Authors:  Yingchun Tang; Xiahui Weng; Chang Liu; Xing Li; Chao Chen
Journal:  Anal Cell Pathol (Amst)       Date:  2021-11-09       Impact factor: 2.916

5.  Temporally Altered miRNA Expression in a Piglet Model of Hypoxic Ischemic Brain Injury.

Authors:  Sophie Casey; Kate Goasdoue; Stephanie M Miller; Gary P Brennan; Gary Cowin; Adam G O'Mahony; Christopher Burke; Boubou Hallberg; Geraldine B Boylan; Aideen M Sullivan; David C Henshall; Gerard W O'Keeffe; Catherine Mooney; Tracey Bjorkman; Deirdre M Murray
Journal:  Mol Neurobiol       Date:  2020-07-27       Impact factor: 5.682

Review 6.  Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review.

Authors:  Ge Guo; Juhua Zhou; Xiaogaung Yang; Jiang Feng; Yanxia Shao; Tingting Jia; Qingrong Huang; Yanmin Li; Yin Zhong; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Integr Cancer Ther       Date:  2018-10-20       Impact factor: 3.279

7.  miR-19 Is a Potential Clinical Biomarker for Gastrointestinal Malignancy: A Systematic Review and Meta-analysis.

Authors:  Xiaoxu Song; Wenyi Li; Peng Shen; Big Bai; Lin-Lin Cao
Journal:  Biomed Res Int       Date:  2020-09-10       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.